Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)
Hospital
Location:
Santander,
Spain (ES)
ISNI: 0000000106274262
ROR: https://ror.org/01w4yqf75
Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study (2018)
Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, et al.
Conference contribution
Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The GREPONET Study (2018)
Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, et al.
Conference contribution
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT (2017)
Heidenreich S, Ziagkos D, De Wreede LC, Van Biezen A, Finke J, Platzbecker U, Niederwieser D, et al.
Journal article
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis (2015)
Ochoa E, Martin JE, Assassi S, Beretta L, Carreira P, Guillen A, Simeon CP, et al.
Journal article
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis (2014)
Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, Assassi S, et al.
Journal article